Glutamate concentration was significantly increased in the stroke patient serums compared with the control serums (Figure 2 and Figure 3), with the highest VIP score (VIP > 2.5, Figure 1b), which is in accordance with reported studies. The gene discussed is VIP; the disease is Stroke.